TriplePoint Venture Growth BDC Corp.
Index- P/E- EPS (ttm)-0.60 Insider Own0.10% Shs Outstand35.31M Perf Week-0.27%
Market Cap398.29M Forward P/E6.09 EPS next Y1.82 Insider Trans11.73% Shs Float34.84M Perf Month-7.26%
Income-20.10M PEG- EPS next Q0.49 Inst Own22.40% Short Float / Ratio5.20% / 6.08 Perf Quarter0.13%
Sales73.40M P/S5.43 EPS this Y-124.80% Inst Trans9.86% Short Interest1.81M Perf Half Y-10.71%
Book/sh11.89 P/B0.93 EPS next Y-3.49% ROA-2.10% Target Price12.38 Perf Year-35.33%
Cash/sh1.44 P/C7.73 EPS next 5Y4.00% ROE-4.70% 52W Range10.10 - 17.81 Perf YTD6.52%
Dividend1.60 P/FCF- EPS past 5Y-20.30% ROI1.80% 52W High-37.63% Beta1.77
Dividend %14.40% Quick Ratio- Sales past 5Y7.40% Gross Margin33.00% 52W Low9.95% ATR0.46
Employees- Current Ratio- Sales Q/Q-75.60% Oper. Margin23.90% RSI (14)41.69 Volatility3.70% 3.98%
OptionableYes Debt/Eq1.35 EPS Q/Q-174.70% Profit Margin-27.30% Rel Volume0.94 Prev Close11.17
ShortableYes LT Debt/Eq1.35 EarningsMar 01 AMC Payout- Avg Volume298.28K Price11.11
Recom2.60 SMA20-5.80% SMA50-5.17% SMA200-10.12% Volume279,169 Change-0.54%
Dec-20-22Downgrade Keefe Bruyette Mkt Perform → Underperform $13 → $10
Dec-13-22Downgrade Piper Sandler Overweight → Neutral $14.50 → $13.50
Dec-01-22Initiated UBS Neutral $13.50
Oct-15-21Downgrade Compass Point Buy → Neutral $15.75
Sep-21-21Upgrade Compass Point Neutral → Buy $15.50 → $16.50
Jul-12-21Initiated Piper Sandler Overweight $17
May-19-21Initiated Oppenheimer Perform
Nov-19-20Resumed JMP Securities Mkt Outperform $13
May-13-20Downgrade Compass Point Buy → Neutral
Apr-02-20Upgrade Compass Point Neutral → Buy $8
Show Previous Ratings
Mar-09-23 05:15AM
Mar-07-23 07:52AM
Mar-06-23 09:30AM
Mar-01-23 07:45PM
04:15PM Loading…
Feb-15-23 04:15PM
Dec-12-22 08:16AM
Nov-08-22 08:16AM
Nov-07-22 09:55AM
Nov-02-22 06:35PM
Oct-19-22 04:15PM
Aug-24-22 09:55AM
Aug-08-22 09:55AM
Aug-04-22 10:30PM
04:30PM Loading…
Aug-03-22 07:45PM
Jul-25-22 04:40PM
Jul-20-22 04:15PM
May-04-22 07:35PM
Apr-20-22 04:30PM
Mar-02-22 07:05PM
Feb-28-22 04:15PM
Feb-23-22 03:00PM
Feb-16-22 04:15PM
Jan-20-22 05:38PM
07:23AM Loading…
Nov-05-21 07:23AM
Nov-03-21 07:55PM
Oct-20-21 05:41PM
Sep-30-21 03:17PM
Aug-04-21 04:15PM
May-06-21 09:17AM
May-05-21 04:15PM
Apr-21-21 04:15PM
Mar-04-21 10:01AM
Mar-03-21 06:25PM
Mar-02-21 10:07AM
Mar-01-21 05:01PM
Feb-17-21 04:15PM
Jan-29-21 04:15PM
Dec-22-20 09:41AM
Dec-21-20 05:06PM
Dec-14-20 05:27PM
Nov-24-20 10:20AM
Nov-09-20 08:14AM
Nov-07-20 01:31AM
Nov-05-20 09:10PM
Nov-04-20 08:01AM
Oct-29-20 12:34PM
Oct-22-20 04:15PM
Sep-30-20 02:03PM
Aug-05-20 04:17PM
Jul-22-20 04:20PM
Jun-14-20 06:41PM
May-07-20 05:00PM
May-06-20 05:55PM
May-01-20 05:29PM
Apr-29-20 04:15PM
Mar-24-20 10:01PM
Mar-19-20 12:55PM
Mar-04-20 04:15PM
Feb-25-20 05:20PM
Feb-12-20 08:57AM
Jan-13-20 04:15PM
Jan-08-20 08:40PM
Dec-30-19 04:15PM
Nov-25-19 11:21PM
Nov-08-19 09:59AM
Nov-06-19 06:45PM
Oct-30-19 07:33PM
Oct-23-19 10:33AM
Oct-01-19 08:59AM
Sep-23-19 04:06PM
Sep-16-19 09:34AM
Sep-05-19 04:45PM
Aug-28-19 02:19AM
Aug-27-19 04:15PM
Aug-21-19 08:31AM
Aug-20-19 07:10AM
Aug-16-19 09:15AM
Aug-15-19 04:15PM
TriplePoint Venture Growth BDC Corp. is a business development company specializing investments in venture capital-backed companies at the growth stage investments. It also provides debt financing to venture growth space companies which includes growth capital loans, secured and customized loans, equipment financings, revolving loans and direct equity investments. The fund seeks to invest in e-commerce, entertainment, technology and life sciences sector. Within technology the areas of focus include: Security, wireless communication equipments, network system and software, business applications software, conferencing equipments/services .big data, cloud computing, data storage, electronics, energy efficiency, hardware, information services, internet and media, networking, semiconductors, software, software as a service, and other technology related subsectors and within life sciences the areas of focus include: biotechnology, bio fuels/bio mass, diagnostic testing and bioinformatics, drug delivery, drug discovery, healthcare information systems, healthcare services, medical, surgical and therapeutic devices, pharmaceuticals and other life science related subsectors. Within growth capital loans it invests between $5 million and $50 million, for equipment financings it invests between $5 million and $25 million, for revolving loans it invests between $1 million and $25 million, and for direct equity investments it may invest between $0.1 million and $5 million (generally not exceeding 5% of the company's total equity). The debt financing products are typically structured as lines of credit and it invests through warrants and secured loans. It targeted returns between 10% and 18%. It does not take board seat in the company.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Vogel Kimberley HDirectorDec 19Buy10.842,76429,9662,764Dec 20 04:05 PM
Fornelli Cynthia M.DirectorDec 19Buy11.151,00011,1506,733Dec 20 04:05 PM
Mathieu Christopher M.Chief Financial OfficerSep 09Buy13.3410,000133,42535,500Sep 12 04:23 PM
Fornelli Cynthia M.DirectorSep 09Buy13.351,00013,3505,540Sep 12 04:22 PM
Mathieu Christopher M.Chief Financial OfficerJun 17Buy12.1610,000121,64625,500Jun 21 04:36 PM
Fornelli Cynthia M.DirectorJun 09Buy14.751,00014,7504,409Jun 10 05:20 PM